Overview of Avitrol Plus
Quick Facts
| Property | Description |
|---|---|
| Active Ingredients | Levamisole and Praziquantel |
| Type | Fixed-dose combination |
| Form | Syrup concentrate and Tablets |
| Pharmacological Class | Anthelmintic (Wormer) |
| Target Audience | Caged birds |
| Origin | Synthetic |
Avitrol Plus: Definition and Pharmacological Classification
Avitrol Plus is a specialized, commercially recognized veterinary medicinal product that functions as a broad-spectrum Anthelmintic, specifically designed for the management and control of parasitic worms in caged birds and various avian species. Its classification within the anthelmintic pharmacological group signifies its core purpose is the elimination or expulsion of parasitic helminths. As a broad-spectrum agent, its efficacy is clinically recognized for providing comprehensive coverage against the two most prevalent classes of parasitic organisms found in its target audience. The active compound, Levamisole, is categorized chemically as an imidazothiazole derivative.
Composition and Available Forms (Levamisole and Praziquantel)
This medication is defined as a fixed-dose combination product, containing two distinct, chemically synthetic active ingredients: Levamisole and Praziquantel. The use of Praziquantel belongs to the pyrazino-isoquinoline class of anthelmintics, and its presence is a key differentiating factor, making the product a unique dual-action solution. Avitrol Plus is offered in multiple dosage forms for oral administration to simplify use in avian subjects, including a liquid syrup concentrate suitable for mixing with drinking water, and in scored tablets for direct dosing.
The Advantage of the Broad-Spectrum Combination
The overall purpose of Avitrol Plus is rooted in the strategic, synergistic combination of its dual components. Levamisole acts primarily as a nematocide, causing rapid, spastic paralysis in roundworm-type parasites. In contrast, Praziquantel operates as a potent cestocide, which achieves its therapeutic effect by damaging the cell membrane permeability of tapeworm-type parasites. This coordinated action provides the required broad-spectrum capability, allowing the product to effectively clear a mixed parasitic burden in avian species, a feature confirmed by pharmacological studies.

